● The prospective high growth for the next fiscal years is among the main assets of the company
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
● For several months, analysts have been revising their EPS estimates roughly upwards.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 106.9 USD
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at USD 173.04.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 635.33 times its estimated earnings per share for the ongoing year.